Hepion Pharmaceuticals HEPA
OTC HEPA
$0.12 0.00 (-2.04%)
As of: Oct 21, 2026 · 12:00 PM EDT

Hepion Pharmaceuticals (HEPA) Short term Debt (2018 - 2021)

Updated

Hepion Pharmaceuticals (HEPA) recorded Short term Debt of $176,585 in Q1 2021.

Analysis

Hepion Pharmaceuticals (HEPA) Short term Debt (2018 - 2021) Analysis & Trends

At the end of FY2018, Hepion Pharmaceuticals reported Short term Debt of $1.44 million.

  • The Q1 2021 figure is the highest quarterly Short term Debt since Q3 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn
10 Hepion Pharmaceuticals 1.11 Mn -10.57 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 176,585.00
Sep 30, 2019 330,000.00
Jun 30, 2019 790,000.00
Mar 31, 2019 1.07 Mn
Dec 31, 2018 1.44 Mn
Sep 30, 2018 2.07 Mn
Jun 30, 2018 2.00 Mn
API Access

Hepion Pharmaceuticals Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=HEPA&period=max&api_key=YOUR_API_KEY